Edward Michael Gilbert

Edward Michael Gilbert, MD

Languages spoken: English

Academic Information

Departments Emeritus - Internal Medicine

Divisions: Cardiovascular Medicine

Board Certification

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Sub: Cardiovascular Disease)

Edward Michael Gilbert, MD is a Professor of Medicine at the University of Utah School of Medicine. Dr. Gilbert received his medical degree from Wayne State University in Detroit, MI. He completed his training in Internal Medicine and in Critical Care at Wayne State University. He completed his Cardiovascular Disease training at the University of Utah School of Medicine. Dr. Gilbert has been on faculty at the University of Utah since 1988 and serves as the Program Director for the Advanced Heart Failure and Transplant Fellowship in the Division of Cardiology at the University of Utah School of Medicine and as the Associate Medical Director of the Utah Transplantation Affiliated Hospitals (UTAH), Cardiac Transplant Program in Salt Lake City, UT. He has been active in clinical work, education and research in the areas of advanced heart failure and heart transplantation.

Education History

Fellowship University of Utah School of Medicine
 Fellow
Fellowship Wayne State University
 Fellow
Residency Wayne State University
 Resident
Internship Wayne State University
 Intern
Professional Medical Wayne State University
 MD
Undergraduate University of Connecticut
 BA

Selected Publications

Journal Article

  1. Bristow MR, Zisman LS, Altman NL, Gilbert EM, Lowes BD, Minobe WA, Slavov D, Schwisow JA, Rodriguez EM, Carroll IA, Keuer TA, Buttrick PM, Kao DP (2020). Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium. JACC Basic Transl Sci, 5(9), 871-883. (Read full article)
  2. Michael R Bristow, Lawrence S Zisman, Natasha Lipson Altman, Edward M Gilbert, Brian D Lowes, Wayne A Minobe, Dobromir Slavov, Jessica A Schwisow, Erin M Rodriguez, Ian A Carroll, Thomas A Keuer, Peter M Buttrick, David P Kao SSRN (2020). Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium. JACC Basic Transl Sci.
  3. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2019). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail, 8(4), 302-312. (Read full article)
  4. Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR (2019). Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. PLoS One, 14(8), e0221519. (Read full article)
  5. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant, 38(8), 858-869. (Read full article)
  6. Iosif Taleb, Antigone G Koliopoulou, Anwar Tandar, Stephen H McKellar, Joseph E Tonna, Jose Nativi-Nicolau, Miguel Alvarez Villela, Frederick Welt, Josef Stehlik, Edward M Gilbert, Omar Wever-Pinzon, Jack H Morshedzadeh, Elizabeth Dranow, Craig H Selzman, James C Fang, Stavros G Drakos (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support. Circ Heart Fail, 140(1), 98-100.
  7. Bristow MR, Kao DP, Breathett KK, Altman NL, Gorcsan J 3rd, Gill EA, Lowes BD, Gilbert EM, Quaife RA, Mann DL (2017). Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete? JACC Heart Fail, 5(11), 772-781. (Read full article)
  8. Tita C, Gilbert EM, Van Bakel AB, Grzybowski J, Haas GJ, Jarrah M, Dunlap SH, Gottlieb SS, Klapholz M, Patel PC, Pfister R, Seidler T, Shah KB, Zieliski T, Venuti RP, Cowart D, Foo SY, Vishnevsky A, Mitrovic V (2017). A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail, 19(10), 1321-1332. (Read full article)
  9. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG (2012). Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol, 21(6), 445-54. (Read full article)
  10. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51. (Read full article)
  11. Wachter SB, Gilbert EM (2012). Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application. Cardiology, 122(2), 104-12. (Read full article)
  12. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61. (Read full article)
  13. Bader FM, Islam N, Mehta NA, Worthen N, Ishihara S, Stehlik J, Gilbert EM, Litwin SE (2011). Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function. Transplant Proc, 43(10), 3877-81. (Read full article)
  14. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607. (Read full article)
  15. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG (2011). Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant, 30(2), 144-50. (Read full article)
  16. Kuppahally SS, Michaels AD, Tandar A, Gilbert EM, Litwin SE, Bader FM (2010). Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation? Am J Cardiol, 106(11), 1657-62. (Read full article)
  17. Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Walter Wray D, Bader F, Gilbert EM, Richardson RS (2010). Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol, 299(5), H1653-9. (Read full article)
  18. Bader FM, Gilbert EM, Mehta NA, Bristow MR (2010). Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure. Congest Heart Fail, 16(6), 265-70. (Read full article)
  19. Abraham WT, Aranda JM, Boehmer JP, Elkayam U, Gilbert EM, Gottlieb SS, Hasenfuss G, Kukin M, Lowes BD, OConnell JB, Tavazzi L, Feldman AM, Ticho B, Orlandi C (2010). Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study. Clin Transl Sci, 3(5), 249-53. (Read full article)
  20. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Kfoury AG (2010). Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc, 42(7), 2687-92. (Read full article)
  21. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J (2010). Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant, 29(3), 235-9. (Read full article)
  22. Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund DG (2006). Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg, 133(6), 1612-9. (Read full article)

Review

  1. Gilbert EM, Xu WD (2017). Rationales and choices for the treatment of patients with NYHA class II heart failure. [Review]. Postgrad Med, 129(6), 619-631. (Read full article)

Case Report

  1. Nativi-Nicolau J, Stehlik J, Kelkhoff AJ, Khong B, Truax CM, Revelo MP, Gilbert EM, Drakos S, Wever-Pinzon O, Fang J, Catino A, Khong HT (2022). Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report. Transplant Proc, 54(1), 193-196. (Read full article)
  2. Peritz DC, Linstroth L, Selzman CH, Gilbert EM (2018). Left ventricular perforation after Impella® placement in a patient with cardiogenic shock. Catheter Cardiovasc Interv, 91(5), 894-896. (Read full article)

Letter

  1. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos SG (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. [Letter to the editor]. Circulation, 140(1), 98-100. (Read full article)

Other

  1. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J (2022). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol (6(8), pp. 957-962). United States. (Read full article)
  2. Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR (2019). Correction: Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. PLoS One (14(10), pp. e0224389). United States. (Read full article)